Pune: India’s indigenous mRNA vaccine of Gennova Pharma candidate’s clinical trials soon

[HostileInsurgent]

Pune: Indigenous mRNA vax candidate’s clinical trials soon | Pune News - Times of India

The clinical trials of India’s first indigenous mRNA vaccine candidate — HGCO19 — to assess its safety and immunogenicity against Covid-19 could begi

timesofindia.indiatimes.com

————————————————————————————————————————————————————-

 

[Skull and Bones]

Covid vaccine will have a perpetual demand like the flu vaccine. More options are always better.

 

[HostileInsurgent]

Covid vaccine will have a perpetual demand like the flu vaccine. More options are always better.

More are coming, we will export more and vaccinate more.

 

[Skull and Bones]

More are coming, we will export more and vaccinate more.

These innovations is a showcase to the world about the innovation in our pharmaceutical/biotech sector.

 

[HostileInsurgent]

These innovations is a showcase to the world about the innovation in our pharmaceutical/biotech sector.

2 more indigenous vaccines under development, Johnson and Johnson single dose vaccines will also be produced in India as part of the QUAD. Also Sputnik-V vaccine is being mass manufactured in India. We should focus on APIs more.

These innovations is a showcase to the world about the innovation in our pharmaceutical/biotech sector.

My parents today took the Covishield dose and they are absolutely fine, we should not be afraid of vaccines but should be afraid of the Wuhan Virus.

 

[Skull and Bones]

2 more indigenous vaccines under development, Johnson and Johnson single dose vaccines will also be produced in India as part of the QUAD. Also Sputnik-V vaccine is being mass manufactured in India. We should focus on APIs more.

My parents today took the Covishield dose and they are absolutely fine, we should not be afraid of vaccines but should be afraid of the Wuhan Virus.

I agree. I received the J&J vaccine 2 days back here in US.

Another aspect we Indians should be looking at is the integration of AI and computational modelling into drugs/vaccine development, Indian entrepreneurs should do a case study on companies like AbCellera and Schrodinger, to use either AI or computational model to develop drugs.